The administration of cyclosporine H, an FPR1 antagonist, abolishes the antitumor effect of chemotherapy, suggesting that FPR1 expression in the host and annexin A1 expression in tumor cells are required for the chemotherapeutic inhibition of tumor growth. The gene discussed is ANXA1; the disease is neoplasm.